Medical Use
Medical Uses - BLINCYTO is a bispecific CD19-directed CD3 T-cell engager indicated for the treatment of adult and pediatric patients with - CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%.
Warning & Precautions
Warnings & Precautions:
Infections: Monitor patients for signs or symptoms; treat appropriately.
- Effects on Ability to Drive and Use Machines: Advise patients to refrain from driving and engaging in hazardous occupations or activities such as operating heavy or potentially dangerous machinery while BLINCYTO is being administered.
- Pancreatitis: Evaluate patients who develop signs and symptoms of pancreatitis. Management of pancreatitis may require either temporary interruption or discontinuation of BLINCYTO.
- Preparation and Administration Errors: Strictly follow instructions for preparation (including admixing) and administration.
- Benzyl Alcohol Toxicity in Neonates: Use BLINCYTO prepared with preservative-free saline for neonates.
- Embryo-Fetal Toxicity: May cause fetal harm. Advise females of reproductive potential of the potential risk to the fetus and to use effective contraception.
Documentation Availability
Documentation & Availability:
- Documents required to import BLINCYTO® (blinatumomab) to India?
Blincyto (Blinatumomab) can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- 2 ID proofs along with PAN card details along with attested scanned copies
- Valid doctor prescription scanned copy
- Patient’s diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- The above-mentioned documents and drug availability.
- Import permit if applicable.
Sourcing & Delivery
Sourcing & Delivery:
The Rx4U team has extensive experience in sourcing Blincyto (Blinatumomab) for acute lymphoblastic leukemia (ALL)) around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
FAQ:
What is the Generic Name for the trade name drug Blincyto?
The generic name for Blincyto is Blinatumomab.
Who manufactures Blincyto (Blinatumomab)?
Blincyto (Blinatumomab) is manufactured by Amgen.
Is Blincyto (Blinatumomab) FDA approved?
Yes, Blincyto was approved by the FDA in 2014.
What is the dosage and form of Blincyto (Blinatumomab)?
Blincyto (Blinatumomab) is available in injection form, with 35 mg lyophilized powder in a single-dose vial.
How to order Blincyto (Blinatumomab) online in India?
Blincyto (Blinatumomab) can be ordered online in India through https://rx4u.in/.
Disclaimer - All trademarks and brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide information.
